ArticleOncoimmunology2020

IAP inhibitor, Embelin increases VCAM-1 levels on the endothelium, producing lymphocytic infiltration and antitumor immunity.

Kosei Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.